No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Aromatase Inhibitors
-
Breast Neoplasms / drug therapy*
-
Drug Resistance, Neoplasm
-
Enzyme Inhibitors / therapeutic use
-
Estrogen Antagonists / therapeutic use
-
Estrogens / analysis
-
Female
-
Forecasting
-
Gonadotropin-Releasing Hormone / therapeutic use
-
Humans
-
Progestins / therapeutic use
-
Receptors, Estrogen / analysis
-
Receptors, Estrogen / antagonists & inhibitors
-
Receptors, Progesterone / analysis
-
Receptors, Progesterone / antagonists & inhibitors
-
Survival Rate
-
Tamoxifen / therapeutic use
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Aromatase Inhibitors
-
Enzyme Inhibitors
-
Estrogen Antagonists
-
Estrogens
-
Progestins
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Tamoxifen
-
Gonadotropin-Releasing Hormone